Simulations Plus, Inc. Share Price & Technical Analysis
SLP · $13.34 (-0.30%)
Healthcare / Health Information Services
$13.34
-0.30%
Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. It operates through Software and Services segments. The company offers GastroPlus, which predicts absorption, biopharmaceutics, pharmacokinetics, and pharmacodynamics in humans …
Price chart
Seasonality
May has 4 positive and 1 negative years (last 5 years shown)
8% return in May, 2% avg return in past 3 year May month.
-11% return in 2026, -6% avg return in past 3 years.
Swipe sideways to see all months →
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Yr | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 26 | -8% | -28% | -1% | 18% | 8% | – | – | – | – | – | – | – | -11% |
| 25 | 21% | -13% | -16% | 41% | -7% | -44% | -25% | 10% | 7% | 14% | -1% | 8% | -5% |
| 24 | -15% | 9% | -1% | 9% | 7% | 1% | -17% | -11% | -11% | -15% | 16% | -13% | -41% |
| 23 | 10% | -8% | 15% | -5% | 6% | -2% | 15% | -10% | -7% | -15% | 12% | 15% | 27% |
| 22 | -12% | -8% | 30% | -8% | 2% | 3% | 30% | -6% | -18% | -15% | -2% | -11% | -14% |
Monthly return % by calendar month · historical pattern, not a forecast
Weak · Downtrend · Uptrend
Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. It operates through Software and Services segments. The company offers GastroPlus, which predicts absorption, biopharmaceutics, pharmacokinetics, and pharmacodynamics in humans and animals; and DDDPlus and MembranePlus simulation products. It also provides products based on mechanistic and mathematical models, such as DILIsym, NAFLDsym, ILDsym, IPFsym, RENAsym, MITOsym, OBESITYsym, and Thales products. In addition, the company offers Absorption, Distribution, Metabolism, Excretion, and Toxicity (ADMET) predictor for chemistry-based computer program that takes molecular structures as inputs and predicts their properties; and MedChem Designer, as well as MonolixSuite products for modeling and simulation that allows for population analyses, rapid clinical trial data analyses, and regulatory submissions. Further, it provides clinical-pharmacology-based consulting services, which includes population pharmacokinetic and pharmacodynamic modeling, exposure-response analyses, clinical trial simulations, data programming, and technical writing services in support of regulatory submissions; and early drug discovery services. Additionally, the company offers creative and insightful consulting services to support its quantitative systems pharmacology and other modeling systems. The company serves pharmaceutical, biotechnology, agrochemical, cosmetics, and food industry companies, as well as academic and regulatory agencies. Simulations Plus, Inc. was incorporated in 1996 and is headquartered in Research Triangle Park, North Carolina.
Full AI Q&A, portfolio tracking, and live alerts in the app.
Key metrics
Market cap
$286.11M
P/E ratio
—
52W high
$34.01
52W low
$11.09
Volume
3,00,585
Beta
1.28
Related stocks in Healthcare
Merck & Co Inc Cedear (5…
₹32,900
Abbott Laboratories Cede…
₹30,500
Eli Lilly And Company Ce…
₹25,540
Unitedhealth Group Inc C…
₹17,200
₹6,600
Frequently asked questions
- What is Simulations Plus, Inc. share price today?
- Simulations Plus, Inc. (SLP) last traded around $13.34 on StockPro. Prices refresh every few minutes during market hours.
- What technical signals does SLP have?
- StockPro monitors breakouts, volume spikes, EMA reversals, and momentum for SLP. Download the app for real-time alerts.
- How can I analyze Simulations Plus, Inc. stock?
- Use the price chart, seasonality heatmap, key metrics, and AI insight on this page. For portfolio tracking and push alerts, download StockPro on Android or iOS.